{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:36:38Z","timestamp":1792449398357,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK127786"],"award-info":[{"award-number":["U01 DK127786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK020595"],"award-info":[{"award-number":["P30 DK020595"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99 HL166870"],"award-info":[{"award-number":["K99 HL166870"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK133881"],"award-info":[{"award-number":["R01 DK133881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI153020"],"award-info":[{"award-number":["T32 AI153020"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"Breakthrough T1D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102634","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:45:30Z","timestamp":1771602330000},"page":"102634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Messenger RNA delivery to islet \u03b2 cells using conjugated lipid nanoparticles"],"prefix":"10.1016","volume":"7","author":[{"given":"Jacob R.","family":"Enriquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla T.","family":"Figatner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advaita","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarida","family":"Pratuangtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew V.","family":"Tirrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Tersey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5013-6075","authenticated-orcid":false,"given":"Raghavendra G.","family":"Mirmira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102634_bib1","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cmet.2023.06.018","article-title":"The pathogenic \u201csymphony\u201d in type 1 diabetes: A disorder of the immune system, \u03b2 cells, and exocrine pancreas","volume":"35","author":"Atkinson","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102634_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib3","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib4","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-Cell Function in Patients with New-Onset Type 1 Diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102634_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-Cell Mass in the Natural History of Type 1 Diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2026.102634_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00281-014-0438-4","article-title":"Insulitis in human type 1 diabetes: a comparison between patients and animal models","volume":"36","author":"In't Veld","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.xcrm.2026.102634_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120877","article-title":"\u03b2 Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis","volume":"3","author":"Evans-Molina","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102634_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/db17-1166","article-title":"Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes","volume":"67","author":"Marre","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2026.102634_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-8587(21)00044-9","article-title":"Combination therapy in recent-onset type 1 diabetes","volume":"9","author":"Long","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102634_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S2213-8587(21)00019-X","article-title":"Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"von Herrath","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102634_bib11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S2213-8587(21)00139-X","article-title":"Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Gitelman","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102634_bib12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3456","article-title":"Harmine and exendin-4 combination therapy safely expands human \u03b2 cell mass in vivo in a mouse xenograft system","volume":"16","author":"Rosselot","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006534","article-title":"Restoration of the unfolded protein response in pancreatic \u03b2 cells protects mice against type 1 diabetes","volume":"5","author":"Engin","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41589-021-00852-0","article-title":"ATP-competitive partial antagonists of the IRE1\u03b1 RNase segregate outputs of the UPR","volume":"17","author":"Feldman","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2026.102634_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111011","article-title":"Proinflammatory signaling in islet \u03b2 cells propagates invasion of pathogenic immune cells in autoimmune diabetes","volume":"39","author":"Pi\u00f1eros","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102634_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","article-title":"Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes","volume":"29","author":"Thompson","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102634_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat3386","article-title":"Targeted delivery of antisense oligonucleotides to pancreatic \u03b2-cells","volume":"4","author":"\u00c4mm\u00e4l\u00e4","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102634_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/nl203334c","article-title":"Polymeric nanomaterials for islet targeting and immunotherapeutic delivery","volume":"12","author":"Ghosh","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.xcrm.2026.102634_bib21","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1021\/jacs.0c12043","article-title":"Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell","volume":"143","author":"Knerr","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.xcrm.2026.102634_bib22","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1038\/s41467-023-42725-1","article-title":"An in situ dual-anchoring strategy for enhanced immobilization of PD-L1 to treat autoimmune diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102634_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.xcrm.2026.102634_bib24","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2500From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2026.102634_bib25","first-page":"897","article-title":"The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery","volume":"15","author":"Kularatne","year":"2022","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.xcrm.2026.102634_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/pharmaceutics15010216","article-title":"Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy","volume":"15","author":"Marques","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2026.102634_bib27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jconrel.2024.07.059","article-title":"Effects of phospholipid type and particle size on lipid nanoparticle distribution in vivo and in pancreatic islets","volume":"373","author":"Oguma","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.102634_bib28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.xcrm.2026.102634_bib29","doi-asserted-by":"crossref","first-page":"eade1444","DOI":"10.1126\/sciadv.ade1444","article-title":"Ionizable lipid nanoparticles deliver mRNA to pancreatic \u03b2 cells via macrophage-mediated gene transfer","volume":"9","author":"Melamed","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102634_bib30","article-title":"Precision mRNA Nanomedicine for Targeted Vascular Therapies in ARDS and Atherosclerosis","author":"Zhou","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102634_bib31","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/nm.3009","article-title":"Targeted estrogen delivery reverses the metabolic syndrome","volume":"18","author":"Finan","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102634_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","article-title":"Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation","volume":"42","author":"McLean","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.xcrm.2026.102634_bib34","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems","volume":"119","author":"Leung","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.xcrm.2026.102634_bib35","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1096\/fj.07-8777com","article-title":"A novel enzyme complementation-based assay for monitoring G-protein-coupled receptor internalization","volume":"21","author":"Hammer","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.xcrm.2026.102634_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/1087057108321531","article-title":"A Homogeneous Enzyme Fragment Complementation-Based \u03b2-Arrestin Translocation Assay for High-Throughput Screening of G-Protein-Coupled Receptors","volume":"13","author":"Zhao","year":"2008","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.xcrm.2026.102634_bib37","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","article-title":"Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells","volume":"268","author":"G\u00f6ke","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102634_bib38","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102634_bib39","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1210\/endo.134.5.8156917","article-title":"Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse","volume":"134","author":"Campos","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.102634_bib40","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1210\/en.2013-1223","article-title":"Detection of islet \u03b2-cell death in vivo by multiplex PCR analysis of differentially methylated DNA","volume":"154","author":"Fisher","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.102634_bib41","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/db07-0822","article-title":"Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes","volume":"56","author":"Medarova","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2026.102634_bib42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","volume":"203","author":"Keir","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.102634_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","article-title":"The NOD mouse: a model of immune dysregulation","volume":"23","author":"Anderson","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102634_bib44","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s42255-023-00876-x","article-title":"Delineating mouse \u03b2-cell identity during lifetime and in diabetes with a single cell atlas","volume":"5","author":"Hrovatin","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.xcrm.2026.102634_bib45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fendo.2020.00569","article-title":"Role of the PD-1\/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes","volume":"11","author":"Falcone","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102634_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176136","article-title":"Inhibition of the eukaryotic initiation factor-2\u03b1 kinase PERK decreases risk of autoimmune diabetes in mice","volume":"134","author":"Muralidharan","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102634_bib47","article-title":"Engineered Cytokine-Primed Extracellular Vesicles with High PD-L1 Expression Ameliorate Type 1 Diabetes","volume":"19","author":"Wang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2026.102634_bib48","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1172\/JCI72674","article-title":"Development of a conditionally immortalized human pancreatic \u03b2 cell line","volume":"124","author":"Scharfmann","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102634_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1369\/jhc.2008.951319","article-title":"Expression of the GLP-1 receptor in mouse, rat, and human pancreas","volume":"56","author":"Tornehave","year":"2008","journal-title":"J. Histochem. Cytochem. Off. J. Histochem. Soc."},{"key":"10.1016\/j.xcrm.2026.102634_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.molmet.2016.01.009","article-title":"Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells","volume":"5","author":"Boothe","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.xcrm.2026.102634_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154\u2013155","author":"B\u00f6ttger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.102634_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","article-title":"PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake","volume":"291","author":"Parhiz","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.102634_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102634_bib54","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tomb\u00e1cz","year":"2021","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102634_bib55","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/en.2007-1137","article-title":"Exendin-4 modulates diabetes onset in nonobese diabetic mice","volume":"149","author":"Hadjiyanni","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.102634_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15417-2","article-title":"A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells","volume":"7","author":"Balhuizen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102634_bib57","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00125-010-1714-z","article-title":"A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker","volume":"53","author":"Flamez","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2026.102634_bib58","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cmet.2018.10.007","article-title":"Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic \u03b2 Cells for In Vitro and In Vivo Analysis","volume":"29","author":"Saunders","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102634_bib59","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/biomedicines11041120","article-title":"The Relationship between Type 1 Diabetes Mellitus, TNF-\u03b1, and IL-10 Gene Expression","volume":"11","author":"Dos Santos Haber","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2026.102634_bib60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gt.2015.18","article-title":"\u03b2-cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection","volume":"22","author":"El Khatib","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102634_bib61","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.3390\/ijms24065657","article-title":"BCL-XL Overexpression Protects Pancreatic \u03b2-Cells against Cytokine- and Palmitate-Induced Apoptosis","volume":"24","author":"Perez-Serna","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102634_bib62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102634_bib63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.xcrm.2026.102634_bib64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo-127-1-126","article-title":"Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms","volume":"127","author":"Miyazaki","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.102634_bib72","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molmet.2017.12.007","article-title":"The EndoC-\u03b2H1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates","volume":"8","author":"Tsonkova","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.xcrm.2026.102634_bib65","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41551-018-0284-0","article-title":"Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA","volume":"2","author":"Islam","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.102634_bib66","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1073\/pnas.1505629112","article-title":"Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102634_bib67","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41598-024-52685-1","article-title":"A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient","volume":"14","author":"Schober","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102634_bib68","article-title":"Mouse islet of Langerhans isolation using a combination of purified collagenase and neutral protease","volume":"4137","author":"Stull","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.xcrm.2026.102634_bib69","article-title":"A method for murine islet isolation and subcapsular kidney transplantation","volume":"50","author":"Zmuda","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.xcrm.2026.102634_bib70","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/db07-0830","article-title":"Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12\/15-lipoxygenase are protected from autoimmune diabetes","volume":"57","author":"McDuffie","year":"2008","journal-title":"Diabetes"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:24:18Z","timestamp":1783095858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666379126000510"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102634","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Messenger RNA delivery to islet \u03b2 cells using conjugated lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102634"}}